Cipla Ltd. has announced the resignation of Mr. Pradeep Bhadauria, the Global Chief Scientific Officer and a member of the Management Council. Mr. Bhadauria, who was an employee of Cipla USA Inc., a wholly owned subsidiary, is leaving the organization to pursue external opportunities. His final working day with the company is scheduled for March 31, 2026. The company confirmed the update on March 26, 2026.
Executive Transition Announcement
Pharmaceutical major Cipla Limited issued a general update on 26th March, 2026, regarding a key managerial departure. Mr. Pradeep Bhadauria, serving as the Global Chief Scientific Officer and holding a position on the Management Council, has tendered his resignation.
Details of Departure
The announcement specified that Mr. Bhadauria was an employee of Cipla USA Inc., which operates as a wholly owned subsidiary of the parent Company. The reason cited for his departure is to pursue interests outside of Cipla. His tenure with the organization will officially conclude on 31st March, 2026, establishing this date as his last working day.
Regulatory Filings Confirmation
The information was duly filed with the stock exchanges, referencing Scrip Code 500087 (BSE) and Scrip Symbol CIPLA (NSE). The disclosure was authorized by Mr. Rajendra Chopra, Company Secretary, and digitally signed on the date of the announcement.
Source: BSE
